Whitworth to review Genzyme's operations
This article was originally published in Scrip
Executive Summary
Genzyme's newest board member Ralph Whitworth, principal and co-founder of Relational Investors, is to chair a new strategic planning and capital allocation committee, which is tasked with "reviewing the company's mix of businesses, evaluating the company's overall cost structure, and enforcing an ongoing capital allocation discipline".